Hyperthermic intraperitoneal chemotherapy: Rationale and technique - Wikidata - wikimedia - TriplyDB

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

http://www.wikidata.org/entity/Q34391107

about

Multimodality treatment strategies have changed prognosis of peritoneal metastases Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis Temperature-dependent shape-responsive fluorescent nanospheres for image-guided drug delivery.Evaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC.Organ dysfunction in critically ill cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer.Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System.Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?Preoperative Preparation and Patient Selection for Cytoreductive Surgery and HIPEC Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study.Intraperitoneal chemotherapy: rationale, applications, and limitations.Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.Preventing recurrence of diffuse malignant peritoneal mesothelioma.Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy.Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma.Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis.Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel.A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma.CRS and HIPEC for PMP-Use of the LC-CUSUM to Determine the Number of Procedures Required to Attain a Minimal Level of Proficiency in Delivering the Combined Modality Treatment.Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome?

P2860

Q26769938-00946B4F-5A39-4C44-9122-8BE0BC306883 Q26774538-6B3A6C4F-FB4E-47F8-8859-49A13F9257D5 Q26776201-0DE3EAC7-B295-4CAA-884D-3D5A000DEFCF Q28395895-C6434097-C764-4100-9C5D-B06D1ED29AC6 Q33777635-0EFF0904-162A-4E09-8AC0-91075A3F13EA Q34401647-3043A80E-E1EA-4070-9895-D84ABC13E8ED Q34491336-37808AFB-4095-49C5-A844-6B1EAB450672 Q34580450-FC80B966-489F-4B11-8D02-C7088D2B7986 Q35133095-8C633D0D-3A86-497A-9C30-8EE20F04EC58 Q35167760-7856F874-04DE-490D-9E70-11579CC6875E Q35886105-7A7081A1-AE89-472D-9DE5-61DAAFC0A5F2 Q36104270-A6154ABC-A115-496C-8E55-09EB084602F7 Q36582197-0BDB88C6-B486-43FB-8367-9A14A0D39DC8 Q36758908-7438757F-9C67-46AC-A069-6D6E39DE632C Q36758912-4A37A968-E0C7-45E5-9A1F-B5E0B21F649F Q36758921-1E98E4A2-9AD2-49A0-9343-B64A4CFA2D28 Q36758925-2D8736CE-79EB-4BCD-BE20-2B0353CE9F40 Q36758933-82FCEE9B-A55F-4857-87A1-C4F708EB6687 Q37635345-624FC12A-6D73-4A6C-9210-C01F51972947 Q37658352-C85369C8-BD0A-4755-8B40-7862927517E1 Q38156120-B1279242-CC79-4B60-ADAC-A0092E140339 Q38719149-CD6FFFE5-05ED-4B77-A06E-F661ED26CBDD Q38800565-CF5AE683-3674-443D-8E8C-653DB7E5D366 Q38804709-C23E7E1C-B813-42C0-AFA9-B205CDD7FF88 Q38917015-9A9BDBCD-DD13-4B73-843E-259B72943AEA Q39014341-5B2A467C-A2FD-47F8-95CC-65061AC84322 Q39151711-D8465AA8-C3A5-4D4B-AA79-5AB200A3FEAC Q39406537-78D6A372-A55C-4AB9-8BF3-D9C18A722F36 Q40046782-DC1F1BA3-8EF0-41A4-B6EF-5B6794F80460 Q45730190-A0EF67DD-C10A-4222-97F0-FC47D6D459E3 Q46612918-07879310-0960-4762-81AD-1641288E6B95 Q46840175-9B47809C-ED71-4EA1-A801-0EFF5DEFDA45 Q47131130-F640AD4B-35CE-4FE5-BBE1-09706F81256B Q47165034-214A810D-001C-486E-AD5C-B991BC8FD8FB Q47418219-D7148F5A-B8A8-4C68-A9BD-EB4F4B68949D Q47821560-F23EF595-19FE-4F4E-8BD0-3B514E9C138B Q48183101-78FE32CD-06D0-4002-B633-88557CB82467 Q50076428-0E32D83D-9FCC-4333-9C64-7B3F60C4344F Q51825453-8AE81D1D-A227-476D-A7C8-585D01DE354B Q52877633-B2C3934C-22F3-4508-AAEC-0A5D9237DC4A

P2860

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

http://www.wikidata.org/entity/Q34391107

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@ast

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@en

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@nl

type

label

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@ast

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@en

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@nl

prefLabel

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@ast

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@en

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@nl

P1433

Q34391107-BC197E26-DEF3-45B0-81B6-E5A7510CBD80

P1476

Q34391107-6C1A2ADF-7974-487A-93CC-B50EE912956E

P2093

Q34391107-1536A991-8315-438B-96A7-5971567B545D

Q34391107-9C32195C-12FB-4FD8-B3C4-98C5D288E095

Q34391107-F9BB9711-E77E-46A0-9E9F-F245CED85D20

P2860

Q34391107-3176FC79-F980-4D1E-B0FB-6E962AE99E4B

Q34391107-33C8BB91-FD48-4C26-914F-58D3FC4C4045

Q34391107-36D43268-AB8B-41F0-B1C1-90E4E0B71F65

Q34391107-395055AD-D4E3-4700-9315-54F38130DD39

Q34391107-41DA69D0-3AB6-463E-AAF1-5F0BC53C2647

Q34391107-43F9E10F-B6D1-41DA-ABFC-64A1A42C4DA9

Q34391107-5253C9A2-73BA-4843-85C7-CE1910531BF0

Q34391107-558C3F9B-D635-4598-9924-6288B99B5A89

Q34391107-7874183C-D3EE-404F-B252-DB13EDC49007

Q34391107-78BC0A64-9243-4A61-B1DE-B61427185EFC

P304

Q34391107-BCBA4794-D374-4A62-8F9F-733EF7448A69

P31

Q34391107-573B0F00-6D5F-4082-9020-F5C57A94DBDA

Q34391107-f7c22a86-d202-4ada-a6f2-0a1d79490d96

P356

Q34391107-E0F3A5E2-F5D0-447B-8FED-D7ECEF0B05C9

P433

Q34391107-210734E5-5B63-4808-A978-95EEC1556B73

P478

Q34391107-C6B3E193-8531-467C-8C86-0AD4167061E9

P577

Q34391107-B7667B01-1953-49C8-9FA8-0459A5014566

P5875

Q34391107-BD9F1427-7A20-4AB9-83B7-25701D4A40C9

P698

Q34391107-7AE3EEA4-5432-442D-A4CC-D4BD8D95716F

P921

Q34391107-677B965E-0E3C-4D60-A293-DE64469500C6

P932

Q34391107-9884BFCA-2817-4561-A1F3-CF8ECC5F957F

P356

P1433

World journal of gastrointestinal oncology

P1476

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

@en

P2093

Gloria Ortega-Pérez

http://www.w3.org/2001/XMLSchema#string

Luis A González-Bayón

http://www.w3.org/2001/XMLSchema#string

Santiago González-Moreno

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents.

Carrier solutions for intraperitoneal chemotherapy.

Intraperitoneal taxanes.

The transport barrier in intraperitoneal therapy.

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.

Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion.

Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.

P304

68-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4251/WJGO.V2.I2.68

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49685957

http://www.w3.org/2001/XMLSchema#string

P698

21160924

http://www.w3.org/2001/XMLSchema#string

P921

P932

2999165

http://www.w3.org/2001/XMLSchema#string